Table 3.
Clinical ICU course
| Characteristics | Overall (N = 51) |
Early empiric treatment (n = 31) |
Definitive treatment (n = 20) |
P value |
|---|---|---|---|---|
| New development of organ failurea | ||||
| Shock | 30 (58.8) | 20 (64.5) | 10 (50.0) | 0.461 |
| Renal failure requiring renal replacement therapy | 13 (25.5) | 6 (19.4) | 7 (35.0) | 0.356 |
| Extracorporeal membrane oxygenation | 2 (3.9) | 2 (6.5) | 0 (0.0) | 0.674 |
| Outcomes | ||||
| ICU mortality | 19 (37.3) | 13 (41.9) | 6 (30.0) | 0.573 |
| Length of stay in ICU (days) | 15.0 (6.0–29.0) | 18.0 (8.5–30.5) | 11.0 (5.0–19.0) | 0.162 |
| Hospital mortality | 23 (45.1) | 15 (48.4) | 8 (40.0) | 0.765 |
| Length of stay in hospital (days) | 24.0 (15.5–32.5) | 25.0 (16.0–34.5) | 20.5 (15.5–32.0) | 0.493 |
Data are presented as number (percentage) or as median (interquartile range)
ICU intensive care units
aTwo patients developed shock and renal failure requiring both renal replacement therapy and extracorporeal membrane oxygenation support. Eight patients developed both shock and renal failure requiring renal replacement therapy